Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii (Q34472684)

2 August 2017

1 reference

title

Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii (English)

1 reference

2 August 2017

1 reference

Saccharomyces boulardii

object named as

Saccharomyces boulardii

1 reference

Periti P

1

1 reference

PubMed ID

11760212

2 August 2017

Tonelli F

series ordinal

2

1 reference

2 August 2017

1 October 2001

1 reference

2 August 2017

Journal of Chemotherapy

1 reference

2 August 2017

13

1 reference

2 August 2017

5

1 reference

2 August 2017

473-493

1 reference

2 August 2017

Bacterial interference

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Pro- and prebiotics--the tasty guardian angels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Colonization pattern of the digestive tract by potentially pathogenic microorganisms: colonization-controlling mechanisms and consequences for antibiotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

21 January 2018

Colonization resistance

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Current treatment of sepsis and endotoxaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Apoptosis in sepsis: a new target for therapeutic exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Nutritional support to prevent and treat multiple organ failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

The gastrointestinal tract as a barrier in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Intestinal microflora and the interaction with immunocompetent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Probiotics in man and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part I. Bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Disposition kinetics of Saccharomyces boulardii in man and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Polyamines in human and rat milk influence intestinal cell growth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Saccharomyces boulardii upgrades cellular adaptation after proximal enterectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Treatment and prevention of antibiotic associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing Clostridia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Mechanisms and management of antibiotic-associated diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Influence of postoperative enteral nutrition on postsurgical infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Neuroendocrine mobilization of body fuels after injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Early and sufficient feeding reduces length of stay and charges in surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Lessons learned from studies on immune-nutrition in postoperative patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Clostridium difficile--Associated diarrhea: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Enteric Microflora in IBD: Pathogens or Commensals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Role of selective decontamination in surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Pharmaceutical probiotics for the treatment of anaerobic and other infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

New aspects of probiotics--a novel approach in the management of food allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Pouchitis: result of microbial imbalance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Lactic acid bacteria and human clinical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

Possible role of catheters in Saccharomyces boulardii fungemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2001.13.5.473

10.1179/JOC.2001.13.5.473

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11760212